Sonoma pharmaceuticals to exhibit at upcoming cphi north america conference in philadelphia

Boulder, co / accesswire / march 28, 2023 / sonoma pharmaceuticals, inc. (nasdaq:snoa), a global healthcare leader developing and producing patented microcyn® technology-based stabilized hypochlorous acid (hocl) products for a wide range of applications, including wound, eye, oral and nasal care, dermatological conditions, animal care and disinfectant use, announced that it will be exhibiting at the cphi north america conference in philadelphia, pennsylvania april 25-27, 2023. sonoma pharmaceuticals is seeking to expand its distribution network in north america by adding new partners and distributors.
SNOA Ratings Summary
SNOA Quant Ranking